Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-06-05
2009-06-16
Qian, Celine X (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S085100, C435S375000
Reexamination Certificate
active
07547674
ABSTRACT:
Methods, compositions, and kits for repairing damaged myocardium and/or myocardial cells including the administration cytokines are disclosed and claimed.
REFERENCES:
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5199942 (1993-04-01), Gillis
patent: 5202120 (1993-04-01), Silver et al.
patent: 5543318 (1996-08-01), Smith et al.
patent: 5580779 (1996-12-01), Smith et al.
patent: 5602301 (1997-02-01), Field
patent: 5833975 (1998-11-01), Paoletti et al.
patent: 5906934 (1999-05-01), Grande et al.
patent: 5942235 (1999-08-01), Paoletti
patent: 5990091 (1999-11-01), Tartaglia et al.
patent: 6001934 (1999-12-01), Yamanaka et al.
patent: 6004777 (1999-12-01), Tartaglia et al.
patent: 6099832 (2000-08-01), Mickle et al.
patent: 6110459 (2000-08-01), Mickle et al.
patent: 6117675 (2000-09-01), van der Kooy et al.
patent: 6130066 (2000-10-01), Tartaglia et al.
patent: 6174333 (2001-01-01), Kadiyala et al.
patent: 6255292 (2001-07-01), Liang
patent: 6265189 (2001-07-01), Paoletti et al.
patent: 6329348 (2001-12-01), Crystal et al.
patent: 6547787 (2003-04-01), Altman et al.
patent: 2002/0122792 (2002-09-01), Stegmann
patent: WO 95/14079 (1995-05-01), None
patent: 96/04314 (1996-02-01), None
patent: WO 9945775 (1999-09-01), None
patent: 00/06701 (2000-02-01), None
patent: 00/57922 (2000-10-01), None
Taylor et al. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation. 106(1):2-4, Jul. 2002.
Foley et al. Heart induction: embryology to cardiomyocyte regeneration. Trends Cardiovasc Med. 14(3):121-5, Apr. 2004.
Burkitt et al. Wheater's Functional Histology: A Text and Colour Atlas. Third Ed. New York: Churchill Livingstone, 1996, pp. 107-111.
Nagai et al. Promotion of cardiac regeneration by cardiac stem cells. Circulation Research, vol. 97, pp. 615-617, 2005.
Kanellakis et al. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovascular Research, vol. 70, pp. 117-125, 2006.
Denten et al. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovascular Research, vol. 65, pp. 52-63, 2005.
Mohri et al. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. The Journal of Biological Chemistry, vol. 281, No. 10, pp. 6442-6447, Mar. 2006.
Stedman's Online Medical Dictionary, 27th Edition, entry for “biotechnology”, http://www.stedmans.com/, printed on Oct. 24, 2007.
Merriam-Webster Online Dictionary, entry for “biotechnology”, http://www.m-w.com/, printed on Oct. 24, 2007.
On-line Medical Dictionary, entry for “cardiology”, http://cancerweb.ncl.ac.uk/omd/index.html, printed on Oct. 24, 2007.
Encarta World English Dictionary [North American Edition], entry for “cardiology”, http://encarta.msn.com, Microsoft Corporation, 2007.
Yasuda et al. Single low-dose administration of human recombinant heptocyte growth factor attenuates intimal hyperplasia in a balloon-injured rabbit iliac artery model. Circulation, vol. 101, pp. 2546-2549, May 2000.
Huang, Jul-Han, et al., “Protein Transfer of Preformed MHC-Peptide Complexes Sensitizes Tartet Cells to T Cell Cytolysis,” Immunity, vol. 1, No. 7, 607-613, Oct. 1994.
Ross, Russell, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, 801-809, Apr. 1993.
Sensebe, Luc, et al., The Broad Spectrum of Cytokine Gene Expression by Myoid Cells from the Human Marrow Microenvironment, Stem Cells, vol. 15, 133-143, Nov. 2, 1997.
Wartiovaara, Ulla, et al., “Peripheral Blood Platelets Express VEGF-C and VEGF which are Released during Platelet Activation,” Thromb Haemost, vol. 80, 171-175, 1998.
Mohle, Robert, et al., “Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets,” Proc. Natl. Acad. Sci. USA, vol. 94, No. 2, 663-8, Jan. 21, 1997.
Boyden, Stephen, “The Chemotactic Effect of Mixtures of Antibody and Antigen on Polymorphonuclear Leucocytes,” J. Exptl. Med. vol. 115, 453-456, 1962.
American Heart Association.2001 Heart and Stroke Statistical Update.Dallas, Texas: American Heart Association, 2000.
Bautz, F. et al., “Expression and secretion of vascular endothelial growth factor-A by cytokine stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment.”Exp HematolJun. 2000; 28(6):700-6, abstract only.
Beardsle, M. A. et al., “Rapid turnover of connexin43 in the adult rat heart.”Circ. Res.(1998) 83, 629-635.
Beltrami, C.A. et al., “Structural basis of end-stage failure in ischemic cardiomyopathy in humans.”Circulation(1994) 89, 151-163.
Bianco, P. et al. “Bone marrow stromal stem cells: nature, biology, and potential applications.”Stem Cells(2001) 19:180-192.
Blume et al., “A review of autologous hematopoetic cell transplantation.” Biology of Blood & Marrow Transplantation, (2000) 6: 1-12.
Bodine, D.M. et al., “Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with branulocyte colony-stimulating factor and stem cell factor.”Blood(1994) 84, 1482-1491.
Brier, G. et al., “Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system.”Blood(1996) 87, 630-641.
Brugger et al., “Ex vivo manipulation of hematopoetic stem and progenitor cells. Seminars in Hematology.” (2000), 37 (1): 42-49.
Caceres-Cortes, J.R. et al., “Steel factor sustains SCL expression and the survival of purified CD34+ bone marrow cells in the absence of detectable cell differentiation.”Stem Cells(Jan. 2001) ;19(1):59-70, abstract only.
Chiu et al., “Cellular Cardiomyoplasty: Mycardial Regeneration With Satellite Cell Implantation.”Ann. Thorac. Surg.(1995) 60: 12-18.
Clutterbuck, R.D. et al., “G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia.”Bone Marrow Transplant(Aug. 1997); 20(4);325-32, abstract only.
Coles, J.G. et al., “Inhibition of Human Xenogenic or Allogenic Antibodies to Reduce Xenograft or Allograft Rejection in Human Recipients”. Patent No. WO 95/34581A1, published Dec. 21, 1995, abstract only.
Couper, L.L. et al., “Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1.” (1997)Circ. Res.81, 932-939.
Dinsmore, J. “Procine Cardiomyocytes and Their Use in Treatment of Insufficient Cardiac Function”. Patent No. WO 96/38544, published Dec. 5, 1996, abstract only.
Durocher, D. et al., “The cardiac transciption factors Nkx2-5 and GATA-4 are mutual cofactors.”EMBO J.16, 5687-5696 (1997).
Fielding et al., “Autologous bone marrow transplantation.” Curr. Opin. Hematology, 1994, 1: 412-417.
Gussoni et al., “Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.” Nature 356:435-438 (1992).
Hermann, H. and Aebi, U. “In Subcellular Biochemistry: Intermediate Filaments.” vol. 31 (ed. Herrmann, H. & Harris, E.) 319-362 (Plenum Press, New York, 1998).
Huang H.M. et al., “Optimal proliferation of a hematopoietic progenitor cell line requires either costimulation with stem cell factor or increase of receptor expression that can be replaced by over expression of Bcl-2. Blood.” Apr. 15, 1999;93(8):2569-77.
Ikuta, K. et al., “Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor.”International Journal of Cell Cloning1991; 9:451-460, abstract only.
Janowska-Wieczorek, A. et al., “Autocrine/paracrine mechanisms in human hematopoiesis.”Stem Cells2001; 19:99-107.
Jo, D.Y. et al., “Chemotaxis
Anversa Piero
Orlic Donald
Cooley Godward Kronish LLP
Dunston Jennifer
New York Medical College
Qian Celine X
LandOfFree
Methods and compositions for the repair and/or regeneration... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the repair and/or regeneration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the repair and/or regeneration... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4089214